Research News

NBRI scientists develop herbal hand-sanitiser

  • Posted on: 22 April 2020
  • By: PharmaTutor News

As the demand for sanitizers has increased amid coronavirus outbreak, various laboratories have started the production of sanitizers. In one such endeavour, researchers of the National Botanical Research Institute (NBRI) have developed alcohol-based herbal sanitizer. The product is developed under Council of Scientific and Industrial Research (CSIR)-Aroma Mission as per the World Health Organisation (WHO) guidelines. 

Indian researchers to go for clinical trial of sepsis drug against novel coronavirus

  • Posted on: 22 April 2020
  • By: PharmaTutor News

The Council of Scientific and Industrial Research (CSIR) is leaving no stone unturned in the battle against novel coronavirus. Repurposing of existing drugs is one of the strategies deployed by CSIR. The Council is implementing this strategy by evaluating a an existing drug that is used for treating gram-negative sepsis patients.

Antiviral remdesivir prevents disease progression in monkeys with COVID-19

  • Posted on: 20 April 2020
  • By: Shalini.Sharma

This scanning electron microscope image shows SARS-CoV-2 (round gold objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the U.S.NIAID-RML

Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19, according to National Institutes of Health scientists.

Investigational chimp adenovirus MERS-CoV vaccine protects monkeys

  • Posted on: 20 April 2020
  • By: PharmaTutor News

An investigational vaccine called ChAdOx1 MERS protected two groups of rhesus macaques from disease caused by Middle East respiratory syndrome coronavirus (MERS-CoV).  MERS-CoV is a relative of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19).  National Institutes of Health scientists and colleagues are pursuing similar studies with ChAdOx1 SARS2, a vaccine candidate against SARS-CoV-2. They posted their results(link is external) with ChAdOx1 MERS on a preprint server. The findings are not yet peer-reviewed but are being shared to assist the public health response to COVID-19.

Indian researchers to work for COVID-19 vaccine

  • Posted on: 16 April 2020
  • By: PharmaTutor News

The swell of novel coronavirus appears not abating. In just a few months from the outbreak, it has reached around 210 countries, took lives of more than one lakh people. The numbers are climbing. In an effort to place a hurdle before the runaway train, scientists across the globe are racing to develop a drug that can cure or a vaccine that stop its spread.

Loss of Smell and Taste Validated as COVID-19 Symptoms in Patients with High Recovery Rate : Study

  • Posted on: 15 April 2020
  • By: PharmaTutor News

Loss of smell and taste has been anecdotally linked to COVID-19 infections. In a study published April 12, 2020 in the journal International Forum of Allergy & Rhinology , researchers at UC San Diego Health report the first empirical findings that strongly associate sensory loss with COVID-19, the respiratory disease caused by the novel coronavirus.

UC San Diego researchers move closer to producing heparin in the lab

  • Posted on: 15 April 2020
  • By: PharmaTutor News

In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), University of California San Diego researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not possible.

Pages